The Royal Devon University Healthcare NHS Foundation Trust is leading ground-breaking clinical research that has the potential to transform treatments for neuropsychiatric disorders.
The Royal Devon University Healthcare NHS Foundation Trust is leading ground-breaking clinical research that has the potential to transform treatments for neuropsychiatric disorders.
Delivered in collaboration with the University of Exeter and Devon Partnership NHS Trust, the studies involve using regulated forms of psychedelic drugs. These innovative therapies could prove effective for treating conditions such as post-traumatic stress disorder (PTSD) and major depressive disorder (MDD).
One in six people are thought to be living with a mental health condition in the UK. Those living with such conditions may experience distressing symptoms, which are often managed through therapy and medication.
Professor Celia Morgan, who is leading the work, said:
"Psychedelic treatments provide new hope for individuals living with PTSD and major depressive disorder (MDD), especially those who have not responded to existing treatments.”
Celia continued:
“Psychedelics can aid people to gain new perspectives and process deep emotions, and may also benefit those with PTSD and depression. However, more research is needed to fully understand how these treatments might help across conditions.”
Scores more bobbies to go on the beat after specialist roles cut
South West Water welcomes Government ban on plastic wet wipes and encourages customers to ‘Bin It, Don’t Block It’
Police remind online shoppers to be wary of scams
Young Devon man forgives friend who caused crash that left him permanently paralysed
